ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 55 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $499,609 | -12.0% | 1,647,244 | +0.1% | 0.00% | – |
Q2 2023 | $567,482 | +48237.5% | 1,644,876 | +10.0% | 0.00% | -100.0% |
Q1 2023 | $1,174 | +1.2% | 1,495,549 | +29.0% | 0.00% | 0.0% |
Q4 2022 | $1,160 | -99.8% | 1,159,745 | +98.3% | 0.00% | – |
Q3 2022 | $522,000 | -63.7% | 584,905 | -54.9% | 0.00% | -100.0% |
Q2 2022 | $1,439,000 | +129.9% | 1,296,115 | +187.9% | 0.00% | – |
Q1 2022 | $626,000 | -32.5% | 450,124 | +10.3% | 0.00% | – |
Q4 2021 | $927,000 | -30.2% | 408,269 | +28.1% | 0.00% | -100.0% |
Q3 2021 | $1,329,000 | +81.6% | 318,658 | +106.7% | 0.00% | – |
Q2 2021 | $732,000 | -77.7% | 154,165 | -61.0% | 0.00% | -100.0% |
Q1 2021 | $3,289,000 | +111.6% | 395,304 | +24.7% | 0.00% | +100.0% |
Q4 2020 | $1,554,000 | +2490.0% | 317,130 | +795.5% | 0.00% | – |
Q3 2020 | $60,000 | -66.3% | 35,412 | -43.4% | 0.00% | – |
Q2 2020 | $178,000 | -6.8% | 62,559 | -4.2% | 0.00% | – |
Q1 2020 | $191,000 | -29.0% | 65,278 | -4.2% | 0.00% | – |
Q4 2019 | $269,000 | -45.2% | 68,168 | -30.6% | 0.00% | -100.0% |
Q3 2019 | $491,000 | – | 98,223 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
Jump Financial, LLC | 58,225 | $276,000 | 0.03% |